Filing Details

Accession Number:
0001140361-17-004431
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-03 19:09:09
Reporting Period:
2017-02-01
Filing Date:
2017-02-03
Accepted Time:
2017-02-03 19:09:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611193 W Jeffrey Jacobs C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 200
Fremont CA 94555
Svp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-01 3,000 $0.54 70,510 No 4 M Direct
Common Stock Disposition 2017-02-01 3,000 $12.00 67,510 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2017-02-01 3,000 $0.00 3,000 $0.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,874 2021-08-11 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2016
  2. The option is fully vested and exercisable.